Gadoquatrane Patent Expiration
Gadoquatrane was first introduced by Bayer Healthcare Pharmaceuticals Inc
Gadoquatrane Patents
Given below is the list of patents protecting Gadoquatrane, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ambelvist | US11944690 | Formulation Of Contrast Media And Process Of Preparation Thereof | May 19, 2040 | Bayer Healthcare |
| Ambelvist | US12303573 | Formulation Of Contrast Media And Process Of Preparation Thereof | Nov 21, 2039 | Bayer Healthcare |
| Ambelvist | US10137209 | Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | May 30, 2036 | Bayer Healthcare |
| Ambelvist | US10722601 | Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | May 30, 2036 | Bayer Healthcare |
| Ambelvist | US11491245 | Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | May 30, 2036 | Bayer Healthcare |
| Ambelvist | US12478696 | Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | May 30, 2036 | Bayer Healthcare |
Gadoquatrane's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List